265 related articles for article (PubMed ID: 23537607)
1. Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study.
Ness KK; Jones KE; Smith WA; Spunt SL; Wilson CL; Armstrong GT; Srivastava DK; Robison LL; Hudson MM; Gurney JG
Arch Phys Med Rehabil; 2013 Aug; 94(8):1451-7. PubMed ID: 23537607
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
3. Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.
Bass JK; Liu W; Banerjee P; Brinkman TM; Mulrooney DA; Gajjar A; Pappo AS; Merchant TE; Armstrong GT; Srivastava D; Robison LL; Hudson MM; Krull KR
JAMA Oncol; 2020 Sep; 6(9):1363-1371. PubMed ID: 32729886
[TBL] [Abstract][Full Text] [Related]
4. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.
Gilchrist LS; Marais L; Tanner L
Support Care Cancer; 2014 Feb; 22(2):359-66. PubMed ID: 24072474
[TBL] [Abstract][Full Text] [Related]
6. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Neuropathy, Sensory Processing, and Balance in Survivors of Acute Lymphoblastic Leukemia.
Varedi M; Lu L; Howell CR; Partin RE; Hudson MM; Pui CH; Krull KR; Robison LL; Ness KK; McKenna RF
J Clin Oncol; 2018 Aug; 36(22):2315-2322. PubMed ID: 29812998
[TBL] [Abstract][Full Text] [Related]
8. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).
Bhakta N; Liu Q; Ness KK; Baassiri M; Eissa H; Yeo F; Chemaitilly W; Ehrhardt MJ; Bass J; Bishop MW; Shelton K; Lu L; Huang S; Li Z; Caron E; Lanctot J; Howell C; Folse T; Joshi V; Green DM; Mulrooney DA; Armstrong GT; Krull KR; Brinkman TM; Khan RB; Srivastava DK; Hudson MM; Yasui Y; Robison LL
Lancet; 2017 Dec; 390(10112):2569-2582. PubMed ID: 28890157
[TBL] [Abstract][Full Text] [Related]
9. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
10. Platinum-induced hearing loss after treatment for childhood cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906
[TBL] [Abstract][Full Text] [Related]
11. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.
Ehrhardt MJ; Liu Q; Dixon SB; Caron E; Redd D; Shelton K; Huang IC; Bhakta N; Ness KK; Mulrooney DA; Brinkman TM; Chemaitilly W; Delaney A; Armstrong GT; Srivastava DK; Zaidi A; Robison LL; Yasui Y; Hudson MM
JAMA Netw Open; 2023 Feb; 6(2):e2255395. PubMed ID: 36763361
[TBL] [Abstract][Full Text] [Related]
12. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
13. Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE).
Clark RA; Mostoufi-Moab S; Yasui Y; Vu NK; Sklar CA; Motan T; Brooke RJ; Gibson TM; Oeffinger KC; Howell RM; Smith SA; Lu Z; Robison LL; Chemaitilly W; Hudson MM; Armstrong GT; Nathan PC; Yuan Y
Lancet Oncol; 2020 Mar; 21(3):436-445. PubMed ID: 32066539
[TBL] [Abstract][Full Text] [Related]
14. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
[TBL] [Abstract][Full Text] [Related]
15. Physical fitness in survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort.
Wogksch MD; Howell CR; Wilson CL; Partin RE; Ehrhardt MJ; Krull KR; Brinkman TM; Mulrooney DA; Hudson MM; Robison LL; Ness KK
Pediatr Blood Cancer; 2019 Mar; 66(3):e27506. PubMed ID: 30362255
[TBL] [Abstract][Full Text] [Related]
16. Changes in long term peripheral nerve biophysical properties in childhood cancer survivors following neurotoxic chemotherapy.
Kandula T; Farrar MA; Cohn RJ; Carey KA; Johnston K; Kiernan MC; Krishnan AV; Park SB
Clin Neurophysiol; 2020 Apr; 131(4):783-790. PubMed ID: 32066096
[TBL] [Abstract][Full Text] [Related]
17. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
[TBL] [Abstract][Full Text] [Related]
18. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
[TBL] [Abstract][Full Text] [Related]
19. The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers.
Gilchrist LS; Tanner L
Support Care Cancer; 2013 Mar; 21(3):847-56. PubMed ID: 22993026
[TBL] [Abstract][Full Text] [Related]
20. Interventions for preventing neuropathy caused by cisplatin and related compounds.
Albers JW; Chaudhry V; Cavaletti G; Donehower RC
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD005228. PubMed ID: 24687190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
